Back to discover
Disease
Peanut Hypersensitivity
Active therapeutic pipelineEmerging research
1
Publications
8
Clinical trials
2018
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
AR101 Oral Immunotherapy for Peanut Allergy.
Research2018-11-18The New England journal of medicine
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q1 2027.
Major developments
Major trial resultsHigh impact
Results posted2026-06-02
Upcoming trial readoutWorth watching
Results expected Q1 20272025-08-24
Clinical MilestonesViewHide
Results posted
Results expected
- 2025-08-24A Phase II Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic PatientsResults expected Q1 2027
Recently completed
- 2025-11-01A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut AllergyPrimary completion
Activity timeline3
- 2026-06-02ClinicalA Phase IIb, Open-Label Study of Xolair (Omalizumab) in Peanut-Allergic Subjects Randomized to Study Drug in Study Q2788g (TOPS)Results posted
- 2025-11-01ClinicalA Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut AllergyPrimary completion
- 2025-08-24ClinicalA Phase II Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic PatientsResults expected Q1 2027
Clinical trials
The current development programme across all trial phases.
Clinical programme
8
2
0
6
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Recent publications
Leading journals1
- The New England journal of medicine1
Leading researchers8
- Adelman DC1
- Anagnostou A1
- Assa’ad AH1
- Ben-Shoshan M1
- Beyer K1
- Bindslev-Jensen C1
- Bird JA1
- Blumchen K1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Allergic reaction to peanuts that is triggered by the immune system.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.